KNSA
$15.50
Kiniksa Pharmaceuticals
$.62
4.17%
KNSA
Earnings Whisper ®
N/A
4th Quarter December 2020
Consensus:  ($0.60)
Revenue:  $0.00 Mil
Thursday
Feb 4
After the close
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when KNSA reports earnings?
Beat
Meet
Miss

Where is KNSA's stock price going from here?
Up
Flat
Down
Stock chart of KNSA
Analysts
Summary of analysts' recommendations for KNSA
Score
Grade
Pivots
Resistance
$15.85
$15.53
$15.20

$14.88

Support
$14.55
$14.23
$13.90
Tweet
Growth
Description
Kiniksa Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa Pharmaceuticals Ltd. is based in Massachusetts, United States.